Eli Lilly & Co. (LLY) – Hot M&A
-
Beam Therapeutics (BEAM) to Sell Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease to Eli Lilly for Up to $600M
-
Eli Lilly & Co. (LLY) to Acquire POINT Biopharma (PNT) for $12.50/sh Cash or $1.4B
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LLY Stock Lookup